NIH-funded research R01 grant

Tools that light up cancer and nerves during prostate removal

Official title: Multichannel Fluorescence Guided Surgery Tools Enabling Simultaneous Cancer Margin and Nerve Visualization in Prostatectomy

Funded at Oregon Health & Science University · NIH-11307146 · Data updated 2026-11-12

This project develops cameras and safe fluorescent dyes to show prostate cancer margins and nearby nerves in real time during prostate removal surgery for men with prostate cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOregon Health & Science University
NIH-funded
Lab location1 site (Portland, United States)
Project startMay 10, 2022
Project endApril 30, 2027
Funding year2026
Award (this year)$614,992
NIH project number5R01CA271532-05
Project IDNIH-11307146 on NIH RePORTER

Who could benefit from this research

Could help

Men scheduled to undergo radical prostatectomy for prostate cancer, especially those where surgeons are balancing cancer removal with nerve-sparing decisions, are the ideal candidates.

Less likely to help

People not having prostate surgery—such as those on active surveillance, receiving radiation, or with widespread metastatic disease—would not directly benefit from this surgical imaging approach.

What this research studies

The team is creating a multichannel near-infrared imaging system plus targeted fluorescent probes that label both prostate cancer tissue and the nerve plexus at the same time. They will test probe distribution, safety, and imaging performance in the lab and in preclinical models before integrating the dyes with an intraoperative camera for real-time use. The approach aims to give surgeons clearer visual guidance to remove cancer while avoiding nerve damage. Work includes optimizing contrast agents, imaging hardware, and methods for simultaneous tumor-and-nerve visualization during prostatectomy.

Why it matters

Potential benefit: If successful, this could lower positive surgical margins and reduce nerve injury, helping preserve continence and sexual function after prostatectomy.

How similar studies have gone: Fluorescence-guided surgery is already used clinically with a few FDA-approved dyes, but the specific combination of multichannel, simultaneous tumor-and-nerve visualization during prostatectomy is novel and still under development.

Where this research is happening

  • Oregon Health & Science University
    Portland, United States
    Active

Researchers

  • Principal investigator: Gibbs, Summer Lynne — Oregon Health & Science University
  • Study coordinator: Gibbs, Summer Lynne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.